PD-L2 Expression in Human Tumors: Relevance to Anti-PD-1 Therapy in Cancer

Jennifery Yearley of Merck joined us for Americas Antibody Congress 2016 to discuss ‘PD-L2 expression in human tumors’ In this presentation, learn about how PD-L2 expression in human tumors relates to Anti-PD-1 therapy in cancer. Download this presentation to understand more about: Programmed Cell Death 1 (PD-1) and Pembrolizumab PD-L2 Function as it relates to health & disease PD-L2 in …

Prevention of Recurrent C. difficile Infections (CDI) with Antitoxin Antibody Bezlotoxumab

Alex Therien of Merck joined us for Americas Antibody Congress 2016 to discuss ” prevention of recurrent CDIs with antitoxin antibody bezlotoxumab” . In this presentation learn about Clostridium difficile infections (CDI), why they are a growing concern, and how they can be prevented. Download this presentation to understand more about: The toxins of C. difficile: TcdA and TcdB CDI …

ADCs Targeting Embryonic Pluripotent Stem Cell Markers

Mike Schopperle of CureMeta joined us at Americas Antibody Congress 2016 to discuss ‘ADCs targeting embryoninc pluripotent stem cell markers’ Download this presentation to understand more about: Main focus in cancer drug development: oncogenes Common embryonic element present in all cancers CureMeta’s product engine to generate high specificity and high affinity antibodies to embryonic targets. and much more ! Get …

Xten protein polymer as clinically validated PEG alternative

Dr. Volker Schellenberger of Amunix joined us for Americas Antibody Congress 2016 to discuss ‘ Xten protein polymer as clincially validated PEG alternative’. In this presentation, learn about Xten protein polymer, and its use as high DAR drug linker and for tumor-protease triggered T cell activation . Download this presentation to understand more about: Biodegradable polymer with precisely-controlled structure Xten: …

Translating tumor antigens into a fully human antibody (HuMab-5B1) as a platform to diagnose and tread pancreatic cancer

Dr. Paul Maffuid of MabVax Therapeutics joined us for Americas Antibody Congress 2016 to discuss ‘translating tumor antigens into a fully human antibody as a platform to diagnose and treat pancreatic cancer ‘. In this presentation, learn about the evolution of MabVax HuMab Platform technology. Download this presentation to understand more about: HuMab Discovery Platform MabVax’s rich pipeline of potential …

Success Factors in the Design and Development of ADCs

Dr. John Lambert of ImmunoGen, Inc. joined us for Americas Antibody Congress 2016 to discuss ‘success factors in the design and development of ADCs ‘. In this presentation, learn about what factors affect the potential for success in ADC design and development. Download this presentation to understand more about: ADC (antibody) distribution Optimizing ADC design Development of new payload platform …

MS/MS Sequencing of Native Human Antibodies

Dr. Adrian Guthals of Mapp Biopharmaceuticals joined us for Americas Antibody Congress 2016 to discuss ‘MS/MS sequencing of native human antibodies’ Download this presentation to understand more about: Mass spectrometry Limitations of De Novo Peptide Sequencing Light chain variants and heavy chain variants and much more! Get your copy here! If you’re interested in learning more about native human antibodies, …

Human Monoclonal Antibodies against Emerging Viruses

Dimiter Dimitrov of National Cancer Institute, NIH joined us for Americas Antibody Congress 2016 to discuss ‘human monoclonal antibodies against emerging viruses’. In this presentation, learn about the correlation between human monoclonal antibodies and emerging viruses. Download this presentation to understand more about: Identification of mAbs by phage and yeast display from libraries of native human antibody fragments Libraries of …

Developing a cell-penetrating antibody into a clinic-ready platform with widespread utility as a functional intra-cellular delivery vehicle

Dr. Dustin Armstrong of Valerion Therapeutics, LLC joined us for Americas Antibody Congress 2016 to discuss ‘developing a cell-penetrating antibody into a clinic-ready platform with widespread utility as a functional intra-cellular delivery vehicle‘ In this presentation, learn about VAL-1205: a functional intracellular delivery vehicle . Download this presentation to understand more about: Platform considerations Cell-free and in vitro data Functional …

Andrew Hiatt of Mapp's 2015 Presentation

Mapp shares lessons learned from Ebola

We were excited to have Andrew Hiatt, CSO of Mapp, gave a keynote address titled “Lessons from Ebola – Pandemic preparedness and antibodies against infectious diseases” at last year’s Americas Antibody Congress. Download his presentation now > You can now download his presentation to find out more about: Typical symptoms of the Ebola virus disease Emerging treatments Antibody failures Neutralization …